Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Gilles Peytavin et al.|The Lancet Infectious Diseases|2021Cited by 344
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in FrancePaul Loubet, E. Dupeyrat, N. Lenzi et al.|Clinical Microbiology and Infection|2016Cited by 109
After 2 years of the COVID-19 pandemic, translating One Health into action is urgentThierry Lefrançois, Bruno Lina, Denis Malvy et al.|The Lancet|2022Cited by 104
Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countriesSimon Galmiche, Yazdan Yazdanpanah, Camille Coustaury et al.|BMC Global and Public Health|2024Cited by 9